INSIGHTS ON CLINICAL TRIAL PARTNERING
-
![The Evolution of GLP-1s]( "The Evolution Of GLP-1s: Overcoming Clinical Development Challenges")
The Evolution Of GLP-1s: Overcoming Clinical Development ChallengesExplore clinical development trends, recruitment hurdles, study design strategies, and emerging therapies shaping obesity and metabolic disease research.
-
![clinical-trial-study-design-GettyImages-2215843204]( "Harness An Adept IRB's Expertise To Streamline Study Design")
Harness An Adept IRB's Expertise To Streamline Study DesignAn Institutional Review Board protects human research participants by evaluating study ethics, consent, and risks, while providing sponsors with ongoing guidance on complex trial protocols.
-
![Choose eClinical Software Built for the Full Study Lifecycle, Not Just Startup]( "Choose eClinical Software Built for the Full Study Lifecycle, Not Just Startup")
Choose eClinical Software Built for the Full Study Lifecycle, Not Just StartupThis clip explores why choosing an RTSM partner requires more than fast startup timelines, highlighting how long‑term flexibility and operational durability matter far more once a study is underway.
-
![GettyImages-1156853489 eSource]( "The State Of eSource Adoption In Clinical Trials")
The State Of eSource Adoption In Clinical TrialsLearn how eSource-ready sites are improving trial efficiency, reducing site burden, and becoming essential to modern clinical trial execution.
-
Building A Gold Standard Trial Experience In Japan4/4/2025
Hear how Medable worked with a Japanese sponsor to elevate their trial experience, achieve >90% patient and site adherence, and beat their forecasted FPI date, creating new eCOA standards adopted across all the customer’s vendors.
-
Clinical Trial Travel Reimbursements Keep Research Moving2/4/2026
Fair, transparent reimbursement systems improve accessibility, trust, and study retention. Clear, timely travel payments strengthen research participation and ease site administrative strain.
-
The ctDNA Clinical Trial Advantage5/27/2026
See how CROs are helping shape the future of ctDNA research—translating emerging data, regulatory insights, and biomarker innovation into faster, smarter oncology development.
-
Big Futures For Emerging Biopharma: Navigating Biotech Hurdles1/14/2026
Emerging biopharma drives agile, data-driven, patient-focused drug development. Discover how to overcome complexity, speed timelines, and thrive in a fast-changing healthcare landscape.
-
What Is Interactive Response Technology (IRT)?6/25/2026
Learn how protocol-driven IRT systems support supply management and randomization to help trial teams cut risk and costs.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
![Kidneys]( "Turnkey Solutions For Your Renal And Hepatic Impairment Studies")
With three clinical pharmacology units, access to 145,000+ hepatic/renal patients, and 100+ completed studies, we’re your partner for NDA-enabling trials.
-
![GettyImages-179973335 budget]( "IQVIA GrantPlan: Confidently Forecast And Budget Investigator Grants")
Learn how to build more accurate study budgets while reducing costs and improving start-up times.
-
![Clinical Trial Services for Phase 1-3 Studies]( "Clinical Trial Services For Phase 1-3 Studies")
Mobile ophthalmic clinical research and clinical trial on-site support services designed to address challenges across all trial phases and ensure reliable protection of ocular endpoints.
-
![cro-vendor-selection-GettyImages-1220794892]( "Advancing Proof-Of-Concept Clinical Trials")
Support proof-of-concept trials with integrated clinical and CRO capabilities spanning study design, site selection, patient recruitment, monitoring, and data delivery.
-
![Scientist with microscope-GettyImages-543355608]( "Bringing Hematologic Oncology Therapies To Cancer Patients")
Blood cancer trials bring complex protocols, shifting care standards, and tough enrollment. Learn how specialized expertise helps sponsors move therapies from first study to approval faster.
